CFTR and cystic fibrosis: In conclusion, furin offers an attractive therapeutic target to target airways dehydration in CF caused by loss of CFTR-mediated chloride secretion and the resulting unrestrained ENaC activity as well as other key aspects of the disease, including infective, inflammatory and remodelling processes.